Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023:1415:183-187.
doi: 10.1007/978-3-031-27681-1_27.

Exonic Variants that Affect Splicing - An Opportunity for "Hidden" Mutations Causing Inherited Retinal Diseases

Yogapriya Sundaresan  1 , Eyal Banin  1 , Dror Sharon  2
Affiliations
Review

Exonic Variants that Affect Splicing - An Opportunity for "Hidden" Mutations Causing Inherited Retinal Diseases

Yogapriya Sundaresan et al. Adv Exp Med Biol. 2023.

Abstract

Inherited retinal diseases (IRDs) are an extremely diverse group of ocular disorders characterized by progressive loss of photoreceptors leading to blindness. So far, pathogenic variants in over 300 genes are reported to structurally and functionally affect the retina resulting in visual impairment. Around 15% of all IRD mutations are known to affect an essential regulatory mechanism, pre-mRNA splicing, which contributes to the transcriptomic diversity. These variants disrupt potential donor and acceptor splice sites as well as other crucial cis-acting elements resulting in aberrant splicing. One group of these elements, the exonic splicing enhancers (ESEs), are involved in promoting exon definition and are likely to harbor "hidden" mutations since sequence-analyzing pipelines cannot identify them efficiently. The main focus of this review is to discuss the molecular mechanisms behind various exonic variants affecting splice sites and ESEs that lead to impaired splicing which in turn result in an IRD pathology.

Keywords: Exonic splicing enhancers; Exonic variants; Inherited retinal diseases; Splice sites; mRNA splicing.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Wahl MC, Will CL, Lührmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136(4):701–18. - DOI - PubMed
    1. Wang Z, Burge CB. Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA. 2008;14(5):802–13. - DOI - PubMed - PMC
    1. Gehring NH, Roignant JY. Anything but ordinary – emerging splicing mechanisms in eukaryotic gene regulation. Trends Genet. 2021;37(4):355–72. - DOI - PubMed
    1. Bacchi N, Casarosa S, Denti MA. Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. Investig Ophthalmol Vis Sci. 2014;55(5):3285–94. - DOI
    1. Lam BJ, Hertel KJ. A general role for splicing enhancers in exon definition. RNA. 2002;8(10):1233–41. - DOI - PubMed - PMC

LinkOut - more resources